Media Contacts

For more information contact our media team:

Stacy Sevcik
+1 314 529 3062
Send Email >

Next Event

  • e-Health Research International Congress 2016

    Paris, France
    Oct11 – 12, 2016

    Learn More

Kantar Health thought leaders are available to comment on a variety of healthcare- and pharma-industry-related topics. In addition, our proprietary data is available for media use, including patient population sizes, treatment rates and patient-reported behaviors and attitudes.

Welcome to the Kantar Health News Room RSS Feed News

Delivering the most current and unique insights on healthcare trends and news about Kantar Health.

Kantar Health Webinar to Explore "White Bagging" Trend in Oncology

Mar 20, 2014
NEW YORK, March 20, 2014—Kantar Health, a leading global healthcare consulting firm, will host a webinar, “The Evolving Use of White Bagging in Oncology,” at 12pm ET on Tuesday, April 8.

“White bagging” describes physician-administered drugs that are dispensed by a specialty pharmacy and filled through the pharmacy benefit rather than physician buy and bill. In this webinar, Kantar Health will examine the current trend of increased use of white bagging in community oncology practices and the dual drivers of payer encouragement and physician choice. Specialty distributors and group purchasing organizations (GPOs) support “buy and bill” as the primary method of distribution of oncology drugs. However, a diverse array of competing specialty pharmacies (SPs) already commanding the majority of the oral market, continue to make headway into physician buy and bill via white bagging with the support of payers.

The discussion will be led by Don Sharpe, President, Oncology Business Review, and panelists will include:

The webinar is free to attend; registration is available on the event website: http://obroncology.com/webinar/the-evolving-use-of-white-bagging-in-oncology.php.

About Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit www.kantarhealth.com.

Share